D019656DisordersPhysiologyG05.365.590.029.53054850.971946Loss of Heterozygosityplugins:FeaturedVideosFeatured Videosplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDericParkx2N7a6U1DO/RmHllZ0mg9mHvDeric Park41.7886000000000087.598699999999993730Park, DericAssociate Professor31492746de Jonge MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, Segal JP, Puranik R, Hollema H, Rookus MA, van Asperen CJ, van Leeuwen FE, Smit VTHBM, Howitt BE, Bosse T, HEBON GroupClinical cancer research : an official journal of the American Association for Cancer ResearchGermline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity. Clin Cancer Res. 2019 12 15; 25(24):7517-7526.Clin Cancer Res2019-09-06T00:00:002019Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.26247786Lee DH, Zhang Y, Kassam AB, Park MJ, Gardner P, Prevedello D, Henry S, Horbinski C, Beumer JH, Tawbi H, Williams BJ, Shaffrey ME, Egorin MJ, Abounader R, Park DMPloS oneCombined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. PLoS One. 2015; 10(8):e0134426.PLoS One2015-08-06T00:00:002015Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma.Pediatrics-Hematology and Oncology22911110Lingen MW, Szabo ECancer prevention research (Philadelphia, Pa.)Validation of LOH profiles for assessing oral cancer risk. Cancer Prev Res (Phila). 2012 Sep; 5(9):1075-7.Cancer Prev Res (Phila)2012-08-21T00:00:002012Validation of LOH profiles for assessing oral cancer risk.19435921Volchenboum SL, Li C, Li S, Attiyeh EF, Reynolds CP, Maris JM, Look AT, George RECancer researchComparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis. Cancer Res. 2009 May 15; 69(10):4143-9.Cancer Res2009-05-12T00:00:002009Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.0.5338880.011652254research area of0.7290790.037626756subject area forPublic Health Scienceshttp://www.urb-bd.org/UChicago Research Bangladeshhttp://www.uchospitals.edu/physicians/samuel-volchenboum.htmlClinical Pagehttps://voices.uchicago.edu/volchenboum/Sam Volchenboumhttps://ipph.uchicago.edu/Institute for Population and Precision Healthhttps://ome.bsd.uchicago.eduOffice of Master's Educationhttps://allofus.uchicago.edu/Illinois Precision Medicine Consortium – All of Us Research Programhttp://commons.cri.uchicago.eduPediatric Cancer Data Commonshttps://www.chicago-cachet.org/ChicAgo Center for Health and EnvironmenT (CACHET)https://compass.uchicago.edu/Chicago Multiethnic Population and Surveillance Study (COMPASS)SamVolchenboumMedicineNeurologyPathologyUniversity of ChicagoHabibulAhsan32NrAqM1DO/RmHllZ0mg9mHvHabibul Ahsan41.78927490000000-87.601250000000001510Ahsan, HabibulProfessorYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, ProfessorSamuel L.VolchenboumxG5/K7QWEeXakH1rLkPq5g==Samuel L. Volchenboum41.78927490000000-87.6012500000000063Volchenboum, Samuel L.ProfessorMark W.Lingen22tnDKQbOfnamXNnYUHhvWD+6g==Mark W. Lingen41.78927490000000-87.60125000000000864Lingen, Mark W.Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor25490892Goetz MP, Sun JX, Suman VJ, Silva GO, Perou CM, Nakamura Y, Cox NJ, Stephens PJ, Miller VA, Ross JS, Chen D, Safgren SL, Kuffel MJ, Ames MM, Kalari KR, Gomez HL, Gonzalez-Angulo AM, Burgues O, Brauch HB, Ingle JN, Ratain MJ, Yelensky RJournal of the National Cancer InstituteLoss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies. J Natl Cancer Inst. 2014 Dec 08; 107(2).J Natl Cancer Inst2014-12-08T00:00:002014Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.